Compounds > pomalidomide
Page last updated: 2024-09-04

pomalidomide and 4-((1-butyl-3-phenylureido)methyl)-n-hydroxybenzamide

pomalidomide has been researched along with 4-((1-butyl-3-phenylureido)methyl)-n-hydroxybenzamide in 1 studies

Compound Research Comparison

Studies
(pomalidomide)		Trials
(pomalidomide)		Recent Studies (post-2010)
(pomalidomide)		Studies
(4-((1-butyl-3-phenylureido)methyl)-n-hydroxybenzamide)		Trials
(4-((1-butyl-3-phenylureido)methyl)-n-hydroxybenzamide)		Recent Studies (post-2010) (4-((1-butyl-3-phenylureido)methyl)-n-hydroxybenzamide)
62312155224022

Protein Interaction Comparison

ProteinTaxonomypomalidomide (IC50)4-((1-butyl-3-phenylureido)methyl)-n-hydroxybenzamide (IC50)
Histone deacetylase 3Homo sapiens (human)4.2196
Cytochrome P450 2D6Homo sapiens (human)3.02
Cytochrome P450 2C19Homo sapiens (human)3.02
Histone deacetylase 4Homo sapiens (human)9.39
Histone deacetylase 1Homo sapiens (human)1.5097
Histone deacetylase 7Homo sapiens (human)3.445
Histone deacetylase 2Homo sapiens (human)5.259
Polyamine deacetylase HDAC10Homo sapiens (human)3.9353
Histone deacetylase 11 Homo sapiens (human)5.14
Histone deacetylase 8Homo sapiens (human)1.0848
Histone deacetylase 6Homo sapiens (human)0.1536
Histone deacetylase 9Homo sapiens (human)4.36
Histone deacetylase 5Homo sapiens (human)6.62

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barinka, C; Leisten, ED; Li, Z; Liu, J; Novakova, Z; Smith, KA; Tang, W; Wu, H; Xie, H; Yang, K; Zhang, Z1

Other Studies

1 other study(ies) available for pomalidomide and 4-((1-butyl-3-phenylureido)methyl)-n-hydroxybenzamide

ArticleYear
Development of Multifunctional Histone Deacetylase 6 Degraders with Potent Antimyeloma Activity.
    Journal of medicinal chemistry, 2019, 08-08, Volume: 62, Issue:15

    Topics: Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Development; HeLa Cells; Hep G2 Cells; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Humans; MCF-7 Cells; Multiple Myeloma

2019